Healthcare -
Biotechnology - NASDAQ - US
$ 21.06
1.1 %
$ 1.03 B
Market Cap
-11.14
P/E
ELVN - COMMON STOCK
Common Stock ELVN - Enliven Therapeutics, Inc.
41 K
LAST VALUE
540.31%
2 YEAR CAGR
59.27%
5 YEAR CAGR
0.00%
10 YEAR CAGR